Sinovac Biotech – World Class Benchmarking
Company: Sinovac Biotech Limited
Bloomberg ticker: SVA US
Market cap: US$640m
Background: Sinovac Biotech Limited is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases
World Class Benchmarking of Sinovac Biotech
- Profitable Growth rank of 8 was same compared to the prior period’s 8th rank
- This is below average performance compared to 400 medium Health Care companies worldwide
- Profitability rank of 8 was better than its Growth rank of 10
- Profitability rank of 8 was the same compared to the prior period’s 8th rank
- This is below average performance compared to peers
- Growth rank of 10 was down compared to the prior period’s 9th rank
- This is poor performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.